Hofstra RM - Search Results

1

Endocrine tumours: progressive metastatic medullary thyroid carcinoma: first- and second-line strategies.

Links TP, Verbeek HH, Hofstra RM, Plukker JT. Links TP, et al. Among authors: hofstra rm. Eur J Endocrinol. 2015 Jun;172(6):R241-51. doi: 10.1530/EJE-14-0726. Epub 2015 Jan 27. Eur J Endocrinol. 2015. PMID: 25627652 Review.

2

The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.

Verbeek HH, Alves MM, de Groot JW, Osinga J, Plukker JT, Links TP, Hofstra RM. Verbeek HH, et al. Among authors: hofstra rm. J Clin Endocrinol Metab. 2011 Jun;96(6):E991-5. doi: 10.1210/jc.2010-2381. Epub 2011 Apr 6. J Clin Endocrinol Metab. 2011. PMID: 21470995

3

Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.

Verbeek HH, Plukker JT, Koopmans KP, de Groot JW, Hofstra RM, Muller Kobold AC, van der Horst-Schrivers AN, Brouwers AH, Links TP. Verbeek HH, et al. Among authors: hofstra rm. J Nucl Med. 2012 Dec;53(12):1863-71. doi: 10.2967/jnumed.112.105940. Epub 2012 Oct 18. J Nucl Med. 2012. PMID: 23081996 Free article.

4

Medullary thyroid cancer in a patient with Hirschsprung disease with a C609Y germline RET-mutation.

de Groot JW, Sijmons RH, Links TP, Plukker JT, Hofstra RM. de Groot JW, et al. Among authors: hofstra rm. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):226-9. doi: 10.1097/00005176-200502000-00028. J Pediatr Gastroenterol Nutr. 2005. PMID: 15699703 No abstract available.

5

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.

de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM. de Groot JW, et al. Among authors: hofstra rm. Endocr Rev. 2006 Aug;27(5):535-60. doi: 10.1210/er.2006-0017. Epub 2006 Jul 18. Endocr Rev. 2006. PMID: 16849421 Review.

6

[Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].

de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra RM, Plukker JT. de Groot JW, et al. Among authors: hofstra rm. Ned Tijdschr Geneeskd. 2006 Feb 11;150(6):311-8. Ned Tijdschr Geneeskd. 2006. PMID: 16503023 Review. Dutch.

7

Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations.

de Groot JW, Plaza Menacho I, Schepers H, Drenth-Diephuis LJ, Osinga J, Plukker JT, Links TP, Eggen BJ, Hofstra RM. de Groot JW, et al. Among authors: hofstra rm. Surgery. 2006 Jun;139(6):806-14. doi: 10.1016/j.surg.2005.10.019. Surgery. 2006. PMID: 16782438 Free article.

8

Medullary thyroid carcinoma and biomarkers: past, present and future.

van Veelen W, de Groot JW, Acton DS, Hofstra RM, Höppener JW, Links TP, Lips CJ. van Veelen W, et al. Among authors: hofstra rm. J Intern Med. 2009 Jul;266(1):126-40. doi: 10.1111/j.1365-2796.2009.02106.x. J Intern Med. 2009. PMID: 19522831 Free article. Review.

9

An introduction to managing medullary thyroid cancer.

de Groot JW, Links TP, Hofstra RM, Plukker JT. de Groot JW, et al. Among authors: hofstra rm. Hered Cancer Clin Pract. 2006 Jul 15;4(3):115-25. doi: 10.1186/1897-4287-4-3-115. Hered Cancer Clin Pract. 2006. PMID: 20223015 Free PMC article.

10

RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.

de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P. de Vries MM, et al. Among authors: hofstra rm. Histopathology. 2012 Nov;61(5):833-43. doi: 10.1111/j.1365-2559.2012.04276.x. Epub 2012 Jul 17. Histopathology. 2012. PMID: 22803838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page